Tara Spivey, MD
Surgical Oncology · Anderson, INNPI 1861756512
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,600 of the $4,152 with a category attached, or 62.6%. Merit Medical Systems Inc accounts for 62.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $2,600 and has fallen 70.7% since, to $763 in 2025.
Across 10 payments — averaging $415.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$3K
- Hologic Inc$763
- Pacira Pharmaceuticals Incorporated$483
- Tactile Systems Technology Inc$114
- Lilly USA, LLC$110
- Endomagnetics Ltd$47
- plus $36 from 2 others
What the payments were for
- Consulting fees$2,60063%
- Travel & lodging$76318%
- Food & beverage$78919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 1 | $2,600 |
| Hologic Inc | 2 | $763 |
| Pacira Pharmaceuticals Incorporated | 1 | $483 |
| Tactile Systems Technology Inc | 1 | $114 |
| Lilly USA, LLC | 1 | $110 |
| Endomagnetics Ltd | 2 | $47 |
| Impedimed, Inc. | 1 | $21 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$483
- Magtrace$451
- Flexitouch Plus$114
- Entre Plus$114
How this compares
Too few surgical oncology providers in Indianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 61 | $497 |
| Oxycodone Hcl | 57 | $167 |
| Cephalexin | 22 | $136 |
| Diazepam | 12 | $17 |
| Tramadol Hcl | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Anderson
- Sharmila Roy-ChowdhuryGoshen$10K
- Jon CardinalIndianapolis$6K
- Ambria MotenFort Wayne$4K
- Timothy GoeddeIndianapolis$3K
- Anne MattinglyDanville$3K
- Monet BowlingDanville$2K
- Nathaniel LeeIndianapolis$2K
- Joshua KaysIndianapolis$717
- Stephanie SchickIndianapolis$606
- Gopal MenonGoshen$555
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.